Annual total expenses:
$23.51B+$4.68B(+24.88%)Summary
- As of today (May 29, 2025), NVO annual total expenses is $23.51 billion, with the most recent change of +$4.68 billion (+24.88%) on December 31, 2024.
- During the last 3 years, NVO annual total expenses has risen by +$10.44 billion (+79.87%).
- NVO annual total expenses is now at all-time high.
Performance
NVO Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$5.54B-$1.45B(-20.78%)Summary
- As of today (May 29, 2025), NVO quarterly total expenses is $5.54 billion, with the most recent change of -$1.45 billion (-20.78%) on March 31, 2025.
- Over the past year, NVO quarterly total expenses has increased by +$660.15 million (+13.53%).
- NVO quarterly total expenses is now -20.78% below its all-time high of $6.99 billion, reached on December 31, 2024.
Performance
NVO Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
NVO Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.9% | +13.5% |
| 3 y3 years | +79.9% | +60.5% |
| 5 y5 years | +125.5% | +113.5% |
NVO Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +79.9% | -20.8% | +69.2% |
| 5 y | 5-year | at high | +125.5% | -20.8% | +132.0% |
| alltime | all time | at high | +7489.5% | -20.8% | +3847.9% |
NVO Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $5.54B(-20.8%) |
| Dec 2024 | $23.51B(+24.9%) | $6.99B(+26.6%) |
| Sep 2024 | - | $5.52B(-9.1%) |
| Jun 2024 | - | $6.08B(+24.6%) |
| Mar 2024 | - | $4.88B(-13.5%) |
| Dec 2023 | $18.83B(+30.0%) | $5.64B(+21.4%) |
| Sep 2023 | - | $4.65B(+4.5%) |
| Jun 2023 | - | $4.44B(+8.7%) |
| Mar 2023 | - | $4.09B(-4.0%) |
| Dec 2022 | $14.48B(+10.8%) | $4.26B(+24.0%) |
| Sep 2022 | - | $3.44B(+4.9%) |
| Jun 2022 | - | $3.27B(-5.1%) |
| Mar 2022 | - | $3.45B(-9.1%) |
| Dec 2021 | $13.07B(+17.2%) | $3.80B(+17.6%) |
| Sep 2021 | - | $3.23B(+9.1%) |
| Jun 2021 | - | $2.96B(-3.0%) |
| Mar 2021 | - | $3.05B(-9.1%) |
| Dec 2020 | $11.16B(+7.0%) | $3.36B(+18.0%) |
| Sep 2020 | - | $2.85B(+19.2%) |
| Jun 2020 | - | $2.39B(-8.0%) |
| Mar 2020 | - | $2.59B(-14.8%) |
| Dec 2019 | $10.43B(+1.9%) | $3.05B(+17.8%) |
| Sep 2019 | - | $2.59B(+3.6%) |
| Jun 2019 | - | $2.50B(+8.9%) |
| Mar 2019 | - | $2.29B(-20.9%) |
| Dec 2018 | $10.23B(+7.1%) | $2.90B(+16.5%) |
| Sep 2018 | - | $2.49B(+2.1%) |
| Jun 2018 | - | $2.44B(+2.0%) |
| Mar 2018 | - | $2.39B(-15.9%) |
| Dec 2017 | $9.55B(+1.4%) | $2.84B(+23.3%) |
| Sep 2017 | - | $2.30B(+2.1%) |
| Jun 2017 | - | $2.26B(+5.2%) |
| Mar 2017 | - | $2.14B(-19.5%) |
| Dec 2016 | $9.42B(+8.2%) | $2.66B(+17.5%) |
| Sep 2016 | - | $2.27B(-0.2%) |
| Jun 2016 | - | $2.27B(+3.1%) |
| Mar 2016 | - | $2.20B(-15.4%) |
| Dec 2015 | $8.70B(-10.2%) | $2.60B(+18.0%) |
| Sep 2015 | - | $2.21B(+2.2%) |
| Jun 2015 | - | $2.16B(+25.6%) |
| Mar 2015 | - | $1.72B(-33.6%) |
| Dec 2014 | $9.69B(+4.5%) | $2.59B(+6.4%) |
| Sep 2014 | - | $2.43B(+2.6%) |
| Jun 2014 | - | $2.37B(+4.9%) |
| Mar 2014 | - | $2.26B(-13.7%) |
| Dec 2013 | $9.27B(+10.6%) | $2.62B(+17.7%) |
| Sep 2013 | - | $2.22B(-0.7%) |
| Jun 2013 | - | $2.24B(+2.0%) |
| Mar 2013 | - | $2.20B(-5.6%) |
| Dec 2012 | $8.38B(+2.1%) | $2.33B(+15.8%) |
| Sep 2012 | - | $2.01B(-1.4%) |
| Jun 2012 | - | $2.04B(+1.8%) |
| Mar 2012 | - | $2.00B(-5.3%) |
| Dec 2011 | $8.21B | $2.12B(+1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | $2.09B(+0.9%) |
| Jun 2011 | - | $2.07B(+8.3%) |
| Mar 2011 | - | $1.91B(-10.9%) |
| Dec 2010 | $7.46B(+11.3%) | $2.15B(+18.3%) |
| Sep 2010 | - | $1.81B(+2.5%) |
| Jun 2010 | - | $1.77B(-0.0%) |
| Mar 2010 | - | $1.77B(-2.1%) |
| Dec 2009 | $6.70B(+2.3%) | $1.81B(+7.2%) |
| Sep 2009 | - | $1.68B(+3.3%) |
| Jun 2009 | - | $1.63B(+7.1%) |
| Mar 2009 | - | $1.52B(-7.2%) |
| Dec 2008 | $6.55B(+8.2%) | $1.64B(+2.9%) |
| Sep 2008 | - | $1.59B(-7.9%) |
| Jun 2008 | - | $1.73B(+10.6%) |
| Mar 2008 | - | $1.56B(-18.4%) |
| Dec 2007 | $6.06B(+21.3%) | $1.92B(+32.7%) |
| Sep 2007 | - | $1.44B(+2.9%) |
| Jun 2007 | - | $1.40B(+6.5%) |
| Mar 2007 | - | $1.32B(-9.1%) |
| Dec 2006 | $4.99B(+16.5%) | $1.45B(+19.8%) |
| Sep 2006 | - | $1.21B(+1.1%) |
| Jun 2006 | - | $1.20B(+5.1%) |
| Mar 2006 | - | $1.14B(-4.5%) |
| Dec 2005 | $4.28B(+15.3%) | $1.19B(+12.4%) |
| Sep 2005 | - | $1.06B(+5.8%) |
| Jun 2005 | - | $1.00B(-1.2%) |
| Mar 2005 | - | $1.01B(-7.3%) |
| Dec 2004 | $3.71B(+20.7%) | $1.09B(+17.6%) |
| Sep 2004 | - | $930.23M(+8.8%) |
| Jun 2004 | - | $854.69M(+1.6%) |
| Mar 2004 | - | $841.19M(-69.4%) |
| Dec 2003 | $3.08B(+26.1%) | $2.75B(+1632.0%) |
| Sep 2003 | - | $158.89M(+3.7%) |
| Jun 2003 | - | $153.19M(+9.2%) |
| Mar 2003 | - | $140.33M |
| Dec 2002 | $2.44B(+12.1%) | - |
| Dec 2001 | $2.18B(+6.0%) | - |
| Dec 2000 | $2.05B(+5.9%) | - |
| Dec 1999 | $1.94B(+6.2%) | - |
| Dec 1998 | $1.83B(-17.8%) | - |
| Dec 1997 | $2.22B(-0.3%) | - |
| Dec 1996 | $2.23B(+5.4%) | - |
| Dec 1995 | $2.11B(+14.9%) | - |
| Dec 1994 | $1.84B(+6.4%) | - |
| Dec 1993 | $1.73B(+9.5%) | - |
| Dec 1992 | $1.58B(+19.6%) | - |
| Dec 1991 | $1.32B(+12.0%) | - |
| Dec 1990 | $1.18B(+31.0%) | - |
| Dec 1989 | $900.04M(+28.8%) | - |
| Dec 1988 | $698.77M(+9.0%) | - |
| Dec 1987 | $641.08M(+47.0%) | - |
| Dec 1986 | $436.13M(+33.9%) | - |
| Dec 1985 | $325.82M(+5.2%) | - |
| Dec 1984 | $309.82M | - |
FAQ
- What is Novo Nordisk A/S annual total expenses?
- What is the all time high annual total expenses for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual total expenses year-on-year change?
- What is Novo Nordisk A/S quarterly total expenses?
- What is the all time high quarterly total expenses for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly total expenses year-on-year change?
What is Novo Nordisk A/S annual total expenses?
The current annual total expenses of NVO is $23.51B
What is the all time high annual total expenses for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual total expenses is $23.51B
What is Novo Nordisk A/S annual total expenses year-on-year change?
Over the past year, NVO annual total expenses has changed by +$4.68B (+24.88%)
What is Novo Nordisk A/S quarterly total expenses?
The current quarterly total expenses of NVO is $5.54B
What is the all time high quarterly total expenses for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly total expenses is $6.99B
What is Novo Nordisk A/S quarterly total expenses year-on-year change?
Over the past year, NVO quarterly total expenses has changed by +$660.15M (+13.53%)